Global

Chemistry Experts

Bluglass

Non Executive Chairman
Nanotechnology
Biomimetics Pty Ltd 
Australia

Biography

  Dr. William Johnson is a seasoned CEO with extensive business development, M&A, technological leadership, and hands-on leadership roles in operations ranging from start-ups to Fortune 500 high technology companies.   ​      

Research Interest

    In 2007 on behalf of Sumitomo Precision Products (SPP), he led the acquisition of assets of Aviza Technology and integrated them with an existing SPP subsidiary, Surface Technology Systems, thereby forming SPTS Technologies, a manufacturer of capital equipment for the semiconductor and related micro-device industries. Serving as President and Chief Executive Officer of SPTS, he orchestrated the 2011 management buy-out of SPTS and the 2014 sale to Orbotech Technologies. ​ Bill recognized the strategic potential of BluGlass in 2010, and had SPTS acquire a cornerstone investment in the company and form a JV with BluGlass to solidify the plasma basis of the RPCVD process. Since 2010 he has served as a non-executive director.   Bill holds 670,000 BluGlass shares Over the years, Bill has held top management positions with high technology companies including Ulvac Corp., Varian Associates, Intevac Inc., Oryx Instruments and Materials Corp., and Therma-Wave, Inc. From 2003-2008, he was founder and managing director of Crane Ridge Associates, providing consulting and M&A guidance to high tech clientele.   In 2007 on behalf of Sumitomo Precision Products (SPP), he led the acquisition of assets of Aviza Technology and integrated them with an existing SPP subsidiary, Surface Technology Systems, thereby forming SPTS Technologies, a manufacturer of capital equipment for the semiconductor and related micro-device industries. Serving as President and Chief Executive Officer of SPTS, he orchestrated the 2011 management buy-out of SPTS and the 2014 sale to Orbotech Technologies. ​ Bill recognized the strategic potential of BluGlass in 2010, and had SPTS acquire a cornerstone investment in the company and form a JV with BluGlass to solidify the plasma basis of the RPCVD process. Since 2010 he has served as a non-executive director.   Bill holds 670,000 BluGlass shares          

Global Experts from Australia

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America